Clinical Trial Update: Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating troriluzole or placebo plus ipilimumab and nivolumab in metastatic brain metastases from melanoma has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Troriluzole (troriluzole)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Melanoma, Metastatic Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2023-12-13